Def Leppard guitarist Vivian Campbell missed the band's first concert of 2025 due to his recovery from cancer treatment.

Campbell, the guitarist for Def Leppard, made headlines this week because he missed the band’s first show of 2025 which took ...

The addition of lenvatinib/pembrolizumab to TACE showed a numerical improvement in PFS, but longer follow-up is necessary to ...

Revolution Medicines, Inc. (NASDAQ:RVMD) has been making waves in the biotechnology sector with its innovative approach to ...

For patients with unresectable, nonmetastatic hepatocellular carcinoma, transarterial chemoembolization (TACE) with ...

EVX-01 is designed with Evaxion’s AI-Immunology™ platform and tailored to target the unique tumor profile and immune characteristics of each individual patient. It engages the patient's immune system ...

In a report released on January 13, Jonathan Chang from Leerink Partners reiterated a Buy rating on Bicycle Therapeutics (BCYC – Research ...

Merck accelerates subcutaneous Keytruda rollout to protect cancer drug's dominance as IV patent nears 2028 expiry.

Merck (MRK) stock in focus as the company eyes 2025 launch of subcutaneous Keytruda amid a looming patent cliff for its ...